Pryor 60mg Tablet
Rx RequiredSalt Composition: Apalutamide
Expiry Date: 01/2028
Price on Request
Inclusive of all taxes
120 Tablet in Bottle
About The Product
Prostate Cancer
Pryor 60mg Tablet is used in the treatment of prostate cancer. This drug is also given to patients who are diagnosed with early stage cancer. This tablet prevents the function of testosterone, which is responsible for cancer cell growth. Eventually, it controls the growth of cancer cells and improves the overall quality of the patient's life. Pryor 60mg Tablet can also be given in combination with other drugs in chemotherapy to increase its effectiveness.
Description
Pryor 60mg Tablet is an anticancer drug consisting of an active ingredient called Apalutamide. The doctor prescribes this medication in prostate cancer specially to those who are detected with early-stage metastatic castration-sensitive and non-metastatic castration-resistant prostate cancer that has spread to other parts of the body and still responds to medical treatment.
Pryor Tablet blocks testosterone function that promotes the growth of cancer cells. As a result, this medicine shrinks the tumor cells and slows down its growth.
It is recommended to take proper consultation with your doctor before using it. Your doctor will decide the dosage and duration of taking the Pryor 60mg Tablet.
Taking it in the wrong way can cause severe side effects. Consult with your medical professional if you've chest pain, indigestion, and seizures.
It should not be given to pregnant and breastfeeding women, as it may pass through the mother and harm the baby. This medicine may cause infertility in males.
Side Effects
Like other anticancer medicines, Pryor 60mg Tablet has mild to severe side effects. These are undesired symptoms observed in the body after taking this tablet. Usually, they disappear with time as the body adjusts to the medicine. These adverse effects don't need special medical attention, but if you observe them continually, talk to your medical expert. Some of them are listed below:
Common side effects:
Fatigue
Diarrhea
Vomiting
Nausea
Joint and muscle pain
High blood pressure
Diabetes
Skin infections
Weight loss
Tiredness and dizziness
Severe Side effects:
Anemia
High cholesterol level
Heart diseases
Seizures
Bones fractures
Swelling in hand and feet
How To Use
- Pryor 60mg Tablet is a prescription-based anticancer drug that should be administered orally.
- It is advised to take this tablet after consulting your healthcare expert.
How It Works
Pryor 60mg Tablet is an anticancer medicine that works by blocking the action of androgen receptors. These receptors are responsible for the growth of cancer cells.
After some, cancer becomes resistant to hormonal treatments. In such situations, androgen receptors keep working and help in the multiplication of cancer cells.
Pryor Tablet stops this process by blocking signals and preventing proteins from entering the cell’s nucleus, which stops the cancer cells from multiplying.
Safety Advice
Missed Doses
- It is advised not to miss any scheduled dosage of Pryor 60mg Tablet.
- In case you miss a dose, consult your doctor immediately.
- Don't overdose to compensate for the missed one.
- Contact your doctor or any healthcare provider and seek medical attention immediately in such cases.
Quick Tips
Pryor 60mg Tablet is not recommended for patients having a history of heart disease, seizures, brain injury, or a recent stroke (within one year).
Your healthcare expert must measure your blood sugar & pressure, potassium level, and liver function tests at regular intervals. Taking the Pryor 60mg Tablet can cause fluctuations in their levels.
Use reliable methods of birth control and contraceptive pills to delay pregnancy while under treatment with Pryor 60mg Tablet. Discuss with your healthcare expert the risks and benefits of taking this medicine if you want to conceive in the future.
FAQs
Pryor 60mg Tablet can cause sterility in men.
It is advised to discuss with your healthcare expert the risks and benefits of taking this medicine if you want to conceive in the future.
Reference
Hegele, A., Häußermann, R., Schultheis, S., Skrobek, L., Vink, M., Hollwegs, S. & Varughese, D. (2024).
Apalutamide for non-metastatic castration-resistant prostate cancer (nmCRPC): real-world data of a multicenter study. Journal of Cancer Research and Clinical Oncology, 150(9), 414.
Hussain, A., Jiang, S., Varghese, D., Appukkuttan, S., Kebede, N., Gnanasakthy, K., & Corman, S. (2022).
Real-world burden of adverse events for apalutamide and enzalutamide-treated non-metastatic castration-resistant prostate cancer patients in the United States. BMC cancer, 22(1), 304.
Monge-Escartín, I., Gil, J., Carrera, C., Sáez-Peñataro, J., Ferrer, L., Aversa, C. & Vilaseca, A. (2024).
Real-world study: Impact of multidisciplinary management of apalutamide-associated adverse events in prostate cancer. The Prostate.
Sánchez, J. C., Picola, N., Rodríguez‐Vida, A., Costa, M., Castañeda, D.
M., Márquez, M. P. & Vilaseca, A.
(2023). Apalutamide for prostate cancer: Multicentre and multidisciplinary real‐world study of 227 patients.
Cancer Medicine, 12(24), 21969-21977. Smith, M.
R., Antonarakis, E. S., Ryan, C.
J., Berry, W. R., Shore, N.
D., Liu, G., & Rathkopf, D. E.
(2025). Phase 2 study of the safety and antitumor activity of apalutamide (ARN-509), a potent androgen receptor antagonist, in the high-risk nonmetastatic castration-resistant prostate cancer cohort.
European urology, 70(6), 963-970. Tohi, Y., Kobayashi, K., Daizumoto, K., Sekino, Y., Fukuhara, H., Niigawa, H. & Sugimoto, M.
(2025). Real-world clinical usage and efficacy of apalutamide in men with nonmetastatic castration-resistant prostate cancer: a multi-institutional study in the CsJUC.
Japanese Journal of Clinical Oncology, 55(6), 643-649.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
.png&w=48&q=75 "Cart"){kind=small}
9655.png&w=48&q=75 "Home"){kind=small}
